{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:44:03Z","timestamp":1790390643686,"version":"4.1.0"},"reference-count":75,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The most common complication seen in inflammatory bowel disease (IBD) patients is iron deficiency anaemia (IDA). Symptoms such as chronic fatigue can be as debilitating to IBD patients as pathological symptoms of abdominal pain and diarrhoea. Recognising and correcting anaemia may be as important as managing IBD symptoms and improving overall quality of life. Thus, iron replacement should be commenced the moment IDA is identified. Although intravenous iron is now considered standard treatment for IBD patients in Europe, oral iron still appears to be the preferred option. Advantages of oral iron include greater availability, lower costs and ease of applicability. However, its multitude of side effects, impact on the microbiome and further exacerbating IBD activity can have consequences on patient compliance. The newer oral iron formulations show promising safety and efficacy data with a good side effect profile. Intravenous iron formulations bypass the gastrointestinal tract absorption thereby leading to less side effects. Multiple studies have shown its superiority compared to oral formulations although its risk for hypersensitivity reactions continue to lead to clinician hesitancy in prescribing this formulation. This article provides an updated review on diagnosis and management of IDA in IBD patients, discussing the newer oral and intravenous formulations.<\/jats:p>","DOI":"10.3390\/nu12113478","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T20:17:52Z","timestamp":1605212272000},"page":"3478","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Iron Therapy in Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-3173","authenticated-orcid":false,"given":"Aditi","family":"Kumar","sequence":"first","affiliation":[{"name":"The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-0292","authenticated-orcid":false,"given":"Matthew J.","family":"Brookes","sequence":"additional","affiliation":[{"name":"The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK"},{"name":"Research Institute in Healthcare Science (RIHS), University of Wolverhampton, Wolverhampton WV1 1LY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000496728","article-title":"Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease","volume":"142","author":"Jimenez","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"D\u2019Amico, F., Peyrin-Biroulet, L., and Danese, S. (2020). Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051536"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00054725-200309000-00005","article-title":"Oral iron therapy in inflammatory bowel disease: Usage, tolerance, and efficacy","volume":"9","author":"Mylonaki","year":"2003","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/01.MIB.0000442728.74340.fd","article-title":"Prevalence in anemia in inflammatory bowel diseases in European countries: A systematic review and individual patient data meta-analysis","volume":"20","author":"Filmann","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_6","first-page":"69","article-title":"Anaemia in inflammatory bowel disease: A population-based 10-year follow-up","volume":"39","author":"Reinisch","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/00365521.2016.1140807","article-title":"Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease","volume":"51","author":"Vegh","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fmed.2014.00058","article-title":"Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?","volume":"1","author":"Rogler","year":"2015","journal-title":"Front. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gut.2010.214312","article-title":"Iron sensing and signalling","volume":"61","author":"Evstatiev","year":"2011","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/gut.2003.035758","article-title":"Iron, anaemia, and inflammatory bowel diseases","volume":"53","author":"Gasche","year":"2004","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Young, I., Parker, H.M., Rangan, A.M., Prvan, T., Cook, R.L., Donges, C.E., Steinbeck, K., O\u2019Dwyer, N., Cheng, H.L., and Franklin, J. (2018). Association between Haem and Non-Haem Iron Intake and Serum Ferritin in Healthy Young Women. Nutrients, 10.","DOI":"10.3390\/nu10010081"},{"key":"ref_12","first-page":"G397","article-title":"Mechanistic and regulatory aspects of intestinal iron absorption","volume":"307","author":"Gulec","year":"2014","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.3748\/wjg.14.4101","article-title":"Mechanisms of heme iron absorption: Current questions and controversies","volume":"14","author":"Adrian","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bhandari, S., Pereira, D.I.A., Chappell, H.F., and Drakesmith, A. (2018). Intravenous Irons: From Basic Science to Clinical Practice. Pharmaceuticals, 11.","DOI":"10.3390\/ph11030082"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","article-title":"Iron deficiency anemia in inflammatory bowel disease","volume":"6","author":"Kaitha","year":"2015","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756284818769074","article-title":"Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease","volume":"11","author":"Niepel","year":"2018","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nielsen, O.H., Soendergaard, C., Vikner, M.E., and Weiss, G. (2018). Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease. Nutrients, 10.","DOI":"10.3390\/nu10010082"},{"key":"ref_19","unstructured":"World Health Organisation (2007). Centers for Disease Control and Prevention. Assessing the Iron Status or Populations, World Health Organisation. [2nd ed.]."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.crohns.2012.07.031","article-title":"State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease","volume":"7","author":"Reinisch","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.crohns.2011.02.002","article-title":"Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease","volume":"5","author":"Oustamanolakis","year":"2011","journal-title":"J. Crohns Colitis"},{"key":"ref_23","first-page":"104","article-title":"Management of iron deficiency anemia in inflammatory bowel disease\u2014A practical approach","volume":"26","author":"Stein","year":"2013","journal-title":"Ann. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1097\/MD.0000000000000963","article-title":"Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease","volume":"94","author":"Nielsen","year":"2015","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1572-0241.2008.01846.x","article-title":"Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel Disease","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD","volume":"7","author":"Stein","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_28","unstructured":"World Health Organization (2017). Nutritional Anaemias: Tools for Effective Prevention and Control, World Health Organisation."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/ibd.20925","article-title":"Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1365-2036.2006.03146.x","article-title":"Systematic review: Managing anaemia in Crohn\u2019s disease","volume":"24","author":"Kulnigg","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Ram\u00edrez, S., Brilli, E., Tarantino, G., and Mu\u00f1oz, M. (2018). Sucrosomial\u00ae Iron: A New Generation Iron for Improving Oral Supplementation. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040097"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jtemb.2012.03.015","article-title":"Intestinal iron absorption","volume":"26","author":"Fuqua","year":"2012","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(17)30182-5","article-title":"Iron absorption from oral iron supplements given on consecutive versus alternate daus and as single morning doses versus twice-daily split dosing in iron-depleted women: Two open-label, randomised controlled trials","volume":"4","author":"Stoffel","year":"2017","journal-title":"Lancet Haematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","article-title":"Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women","volume":"126","author":"Moretti","year":"2015","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Khoury, A.P., Pagan, K.A., and Farland, M.Z. (2020). Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults. Ann. Pharmacother.","DOI":"10.1177\/1060028020941014"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MIB.0000000000000314","article-title":"Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: Results from a phase 3 clinical trial program","volume":"21","author":"Asche","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S478","DOI":"10.1093\/ecco-jcc\/jjz203.695","article-title":"P567 Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron","volume":"14","author":"Howaldt","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"ref_38","unstructured":"Accrufer (2020, October 15). Package Insert; Shield Therapeutics 2019, UK, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/212320Orig1s000lbl.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-020-01716-w","article-title":"Oral Sucrosomial\u00ae iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: A cost-minimization analysis","volume":"21","author":"Riccio","year":"2020","journal-title":"BMC Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11739-018-1993-9","article-title":"Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia","volume":"14","author":"Abbati","year":"2018","journal-title":"Intern. Emerg. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1093\/ecco-jcc\/jjz203.460","article-title":"P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV iron","volume":"14","author":"Howaldt","year":"2020","journal-title":"J. Crohns Coliti"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.beha.2004.08.022","article-title":"Diagnosis and management of iron-deficiency anaemia","volume":"18","author":"Cook","year":"2005","journal-title":"Best Pr. Res. Clin. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ibd.20285","article-title":"Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases","volume":"13","author":"Gasche","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","article-title":"Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD","volume":"66","author":"Lee","year":"2016","journal-title":"Gut"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"763576","DOI":"10.1155\/2015\/763576","article-title":"Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations","volume":"2015","author":"Koch","year":"2015","journal-title":"Anemia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.3748\/wjg.v22.i35.7908","article-title":"Anemia and iron deficiency in gastrointestinal and liver conditions","volume":"22","author":"Stein","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","article-title":"Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis","volume":"6","author":"Lee","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety","volume":"2010","author":"Auerbach","year":"2010","journal-title":"Hematology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.3748\/wjg.15.4666","article-title":"Intravenous iron in inflammatory bowel disease","volume":"15","author":"Rez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_51","unstructured":"Venofer (Iron Sucrose) (2020, October 15). Electronic Medicines Compendium. Available online: https:\/\/www.medicines.org.uk\/emc\/product\/5911\/smpc#gref."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","article-title":"Intravenous iron sucrose is superior to oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2014A randomised, controlled, open-label, multicentre study","volume":"100","author":"Mickisch","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2362.2002.0320s1036.x","article-title":"Non-transferrin bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion","volume":"32","author":"Kooistra","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_54","unstructured":"Ferrinject (Ferric Carboxymaltose) (2020, October 15). Electronic Medicines Compendium. Available online: https:\/\/www.medicines.org.uk\/emc\/product\/5910\/smpc#gref."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT\u00ae) Randomized Controlled Trial","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease","volume":"141","author":"Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajh.20056","article-title":"Parenteral iron therapy options","volume":"76","author":"Silverstein","year":"2004","journal-title":"Am. J. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/11209880-000000000-00000","article-title":"Ferumoxytol: In iron deficiency anaemia in adults with chronic kidney disease","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.02840608","article-title":"Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients","volume":"4","author":"Provenzano","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2146\/ajhp110262","article-title":"Compariuson of rates of reported adverse events associated with i.v. iron products in the United States","volume":"69","author":"Bailie","year":"2012","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13244-013-0262-8","article-title":"Parenteral ferumoxytol interaction with magnetic resonance imaging: A case report, review of the literature and advisory warning","volume":"4","author":"Schieda","year":"2013","journal-title":"Insights Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IJNRD.S89704","article-title":"Efficacy and safety of iron isomaltoside (Monofer\u00ae) in the management of patients with iron deficiency anemia","volume":"9","author":"Kalra","year":"2016","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_64","unstructured":"Monofer (2020, October 15). Electronic Medicines Compendium. Available online: https:\/\/www.medicines.org.uk\/EMC\/medicine\/23669\/SPC\/Monofer+100%C2%A0mg+ml+solution+for+injection+infusion\/#gref."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/00365521.2018.1498914","article-title":"Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice","volume":"53","author":"Stein","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","article-title":"Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: A systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Bonovas","year":"2006","journal-title":"Medicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/CEOR.S150900","article-title":"Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany\u2014A real-world evidence analysis","volume":"10","author":"Stein","year":"2018","journal-title":"Clin. Outcomes Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: Guidance for risk minimization and management","volume":"99","author":"Rampton","year":"2014","journal-title":"Haematologica"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/ajg.2011.232","article-title":"Supplementation With Oral vs. Intravenous Iron for Anemia With IBD or Gastrointestinal Bleeding: Is Oral Iron Getting a Bad Rap?","volume":"106","author":"Rizvi","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_70","first-page":"197","article-title":"On both sides of the ocean","volume":"14","author":"Jimenez","year":"2016","journal-title":"Blood Transfus."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/MIB.0000000000000386","article-title":"Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"21","author":"Abhyankar","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tmrv.2013.04.001","article-title":"Restrictive vs. Liberal Blood Transfusion for Acute Upper Gastrointestinal Bleeding: Rationale and Protocol for a Cluster Randomized Feasibility Trial","volume":"27","author":"Jairath","year":"2013","journal-title":"Transfus. Med. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.3748\/wjg.v13.i36.4798","article-title":"Stimulating erythropoiesis in inflammatory bowel disease associated anemia","volume":"13","author":"Tsiolakidou","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMp0912328","article-title":"Erythropoiesis-Stimulating Agents\u2014Time for a Reevaluation","volume":"362","author":"Unger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0016-5085(09)63038-9","article-title":"W1124 Rapid Recurrence of IBD-Associated Anemia and Iron Deficiency After Intravenous Iron Sucrose and Erythropoietin Treatment","volume":"136","author":"Kulnigg","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/11\/3478\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:32:42Z","timestamp":1760178762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/11\/3478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":75,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["nu12113478"],"URL":"https:\/\/doi.org\/10.3390\/nu12113478","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}